The absence of institutional selling and the entry of a major sovereign wealth fund suggest strong underlying demand. Traders should monitor for follow-on buying and potential upward pressure on the stock, especially if active managers begin to join the trend.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $508.29entry
- T+1 · 9mo ago −0.31%α +0.60% · $506.70
- T+5 · 8mo ago +0.34%α +1.55% · $510.01
- T+20 · 8mo ago −5.58%α +2.35% · $479.91
- T+60 · 6mo ago −11.83%α −21.15% · $448.18
How similar events traded
Executive Summary
Three major institutions, Fidelity, Norges Bank, and Two Sigma, significantly increased their positions in Thermo Fisher Scientific during 2025-Q4, collectively adding $5.07 billion in new holdings with no notable selling. The cluster is driven by a mix of passive, sovereign, and quant investors, indicating broad-based confidence in the stock.
Key Financial Metrics
Institutional Positions
Net institutional flow: $5.1B
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Fidelity | ADD | +29% | $5.7B | $2.0B |
| Norges Bank | NEW | +0% | $3.1B | $3.1B |
| Two Sigma | ADD | +32.2% | $7.3M | $2.7M |
Key Facts
- Fidelity added $1.99B to its position, increasing shares by 29.0% to a total value of $5.67B.
- Norges Bank established a new $3.07B position, the largest single addition in the cluster.
- Two Sigma, a quant fund, increased its stake by 32.2% with a smaller but meaningful $2.7M addition.
- No institutional selling was reported among tracked funds in this quarter.
Financial Impact
3 institutions accumulated $5.07B in net new positions during 2025-Q4
Risk Factors
- The cluster includes Fidelity, a mega-passive holder, which may limit price sensitivity impact as their moves could reflect index flows rather than active conviction.
- Limited participation from active value or activist funds reduces the strength of the fundamental thesis signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-TMO-2025-Q4 |
Track record
21 reports on TMO
3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +29.04% at T+60 after the Jun 11, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $700.22 settles Feb 11
- Nov 5, 202611d ago SC 13G Neutral 3/10 Entry $676.94 settles Feb 3
- Oct 30, 202617d ago 8-K Neutral 2/10 Entry $682.65 settles Jan 29
- Oct 28, 202619d ago 144 Neutral 2/10 Entry $709.18 settles Jan 27
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $694.02 settles Jan 19
- Oct 16, 20264w ago Institutional Cluster Neutral 3/10 Entry $690.00 settles Jan 13
- Sep 1, 202610w ago Insider Cluster Neutral 2/10 Entry $608.54 settles Nov 27
- Aug 26, 202611w ago Insider Cluster Neutral 2/10 Entry $630.70 settles Nov 20
- Aug 24, 202612w ago Insider Cluster Neutral 2/10 Entry $628.15 settles Nov 18
- Aug 18, 202613w ago Court Ruling Neutral 1/10 Entry $613.07 to $717.71 ▲ +17.07% +17.89% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers